Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEXAROTENE vs BGB-11417: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BEXAROTENE vs BGB-11417: Safety Overview

Metric BEXAROTENE BGB-11417
Total FAERS Reports 759 123
Deaths Reported 134 40
Death Rate 17.7% 32.5%
Hospitalizations 177 95
Average Patient Age 66.5 yrs 69.2 yrs
% Female Patients 42.3% 38.8%
FDA Approval Date Apr 27, 2022 N/A
Manufacturer Upsher-Smith Laboratories, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A